Opiant Pharmaceuticals In... (OPNT)
NASDAQ: OPNT
· Real-Time Price · USD
20.65
0.00 (0.00%)
At close: Mar 01, 2023, 10:00 PM
Opiant Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2019 |
|---|---|---|
| Grant Revenue | 3.3M | 2M |
| Grant Revenue Growth | +65.00% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 29, 2018 | Mar 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.67M | 6.83M | 7.01M | 4.89M | 4.44M | 3.76M | 3.64M | 4.55M | 3.64M | 4.58M | 3.65M | 3.28M | 3.35M | 3.73M | 3.7M | 2.26M | 3.4M | 2.86M | 2.96M | 4.02M | 2.29M | 2.08M | 2.55M | 1.26M | 1.48M | 1.13M | 2.49M | 10.79M | 1.32M | 1.86M | 2.14M |
| Selling, General, and Administrative Revenue Growth | -16.94% | -2.61% | +43.33% | +10.18% | +18.13% | +3.10% | -19.96% | +24.98% | -20.51% | +25.56% | +11.31% | -2.15% | -10.18% | +0.95% | +63.68% | -33.55% | +18.94% | -3.64% | -26.24% | +75.47% | +10.13% | -18.48% | +102.86% | -15.06% | +30.95% | -54.51% | -76.96% | +715.03% | -28.97% | -12.86% | n/a |
| Research and Development Revenue | 4.13M | 7.92M | 8.82M | 4.71M | 4.88M | 3.15M | 4.09M | 4.48M | 2.78M | 558.31K | 1.42M | 2.04M | 1.84M | 1.63M | 3.57M | 2.53M | 1.91M | 1.62M | 2.42M | 1.61M | 1.28M | 1.1M | 344.84K | 441.83K | -118K | 1.06M | 373.06K | 429.45K | 1.07M | 96.91K | 1.19M |
| Research and Development Revenue Growth | -47.78% | -10.28% | +87.17% | -3.42% | +54.95% | -22.95% | -8.69% | +60.87% | +398.47% | -60.71% | -30.17% | +10.42% | +12.79% | -54.19% | +40.77% | +32.81% | +18.07% | -33.25% | +50.56% | +25.43% | +16.19% | +219.95% | -21.95% | -474.44% | -111.10% | +184.94% | -13.13% | -60.01% | +1008.29% | -91.87% | n/a |
| Sales and Marketing Revenue | 2.6M | 2.82M | 2.68M | 1.5M | 1.06M | 1.02M | 997.57K | 949.14K | 914.35K | 1.75M | 1.08M | 470.57K | 141K | n/a | n/a | 213.9M | n/a | n/a | n/a | n/a | 328.13K | 84.38K | 1.2M | 42.04K | 317.92K | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -7.78% | +5.19% | +78.94% | +41.13% | +3.62% | +2.55% | +5.10% | +3.80% | -47.66% | +62.21% | +128.87% | +233.74% | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | -100.00% | +288.89% | -92.95% | +2747.56% | -86.78% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |